| mRNA |
TG-100-115 |
CTRPv2 |
pan-cancer |
AAC |
0.0018 |
1 |
| mRNA |
BRD-A05715709 |
CTRPv2 |
pan-cancer |
AAC |
-0.0026 |
1 |
| mRNA |
Lisitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.0015 |
1 |
| mRNA |
MK-2206 |
GDSC1000 |
pan-cancer |
AAC |
0.0015 |
1 |
| mRNA |
OSI-930 |
GDSC1000 |
pan-cancer |
AAC |
-0.0013 |
1 |
| mRNA |
hyperforin |
CTRPv2 |
pan-cancer |
AAC |
-0.0015 |
1 |
| mRNA |
Bortezomib |
GDSC1000 |
pan-cancer |
AAC |
0.0019 |
1 |
| mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0011 |
1 |
| mRNA |
BRD-K27986637 |
CTRPv2 |
pan-cancer |
AAC |
0.0026 |
1 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.00093 |
1 |